The Drug Controller-General of India (DCGI) has commissioned an inquiry into media reports that Bombay-based Sun Pharmaceuticals had been promoting and marketing letrozole, an anti-breast-cancer drug, for treating infertility in women, without the required regulatory approval. Patients with diabetes mellitus should therefore be monitored especially at the beginning or end of treatment and at periodic [...]